<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F0DE12EC-900B-4C67-BB76-67A5C13B8ADC"><gtr:id>F0DE12EC-900B-4C67-BB76-67A5C13B8ADC</gtr:id><gtr:name>Frenchay Hospital</gtr:name><gtr:address><gtr:line1>Frenchay Hospital</gtr:line1><gtr:line2>Frenchay Park Road</gtr:line2><gtr:line3>Frenchay</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:postCode>BS16 1LE</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/64BC5E73-972F-41E1-A12C-D97DC9BDFB93"><gtr:id>64BC5E73-972F-41E1-A12C-D97DC9BDFB93</gtr:id><gtr:name>MRC Clinical Sciences Centre</gtr:name><gtr:address><gtr:line1>Faculty of Medicine Imperial College</gtr:line1><gtr:line2>London Hammersmith Campus</gtr:line2><gtr:line3>Du Cane Road</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>W12 0NN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F0DE12EC-900B-4C67-BB76-67A5C13B8ADC"><gtr:id>F0DE12EC-900B-4C67-BB76-67A5C13B8ADC</gtr:id><gtr:name>Frenchay Hospital</gtr:name><gtr:address><gtr:line1>Frenchay Hospital</gtr:line1><gtr:line2>Frenchay Park Road</gtr:line2><gtr:line3>Frenchay</gtr:line3><gtr:line4>Bristol</gtr:line4><gtr:postCode>BS16 1LE</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7B26620B-FEB9-4EF6-884F-8670FC59E3D6"><gtr:id>7B26620B-FEB9-4EF6-884F-8670FC59E3D6</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Brooks</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U120036861"><gtr:id>BF85D143-451F-4333-9C59-185F2BE5790A</gtr:id><gtr:title>Neurology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U120036861</gtr:grantReference><gtr:abstractText>A major medical priority of the 21st century for the western world is how to cope with problems of ageing. This is our driving force for establishing a programme focussing on the diagnosis, neuroprotection, and restoration of function in Alzheimers and Parkinsons diseases, the two most common late onset neurodegenerative disorders. We will also research into motor neurone disease (amyotrophic lateral sclerosis) and neurodegenerative conditions affecting younger subjects, such as Huntingtons disease. Alzheimers disease (AD) is associated with abnormal deposition of a protein called beta-amyloid in the brain. Using a scanning technique called PET and a radiotracer called PIB we have been studying the prevalence of raised amyloid in patients thought to have AD and subjects with occasional recall problems. In the future we will scan subjects who carry genes that predispose to AD. Amyloid deposition can be reversed by infusing antibodies to this protein. We are monitoring the progression of amyloid deposition in AD and the effects of immunotherapy upon this. Microglia, the natural immune defence of the brain, are activated in AD and surround amyloid plaques and dying neurones. Activated microglia can be detected in vivo with 11C-PK11195 PET and we have been correlating the levels and distribution of cortical inflammation in AD with the distribution and density of amyloid deposition. Addictive behaviour is associated with release of a chemical called dopamine in the brain. In Parkinsons disease (PD) this chemical is deficient. We are using PET imaging to investigate the behaviours that trigger brain dopamine release in healthy subjects and Parkinsons disease (PD) patients. We are also testing the ability of cell implants and infusions of nerve growth factors to restore dopamine levels in PD. We recently demonstrated that intra-putamen infusions of GDNF increase dopamine storage in PD and cause nerve terminal sprouting and that craving for excessive L-dopa treatment in PD is associated with generation of high levels of ventral striatal dopamine. Huntingtons disease (HD) is associated with loss of striatal cells and microglial activation. We have recently shown with PET that grafts of fetal striatal cells grow and survive and can improve HD patients clinically.</gtr:abstractText><gtr:technicalSummary>To investigate in vivo with PET/MRI activation and PET ligand studies: The functional anatomy of motor control in health and disease and its modulation by incentives and aversive stimuli. Changes in release of dopamine and other modulatory neurotransmitters, and opening of voltage gated ion channels during different aspects of motor function. The dysfunctional anatomy and transmitter release underlying bradykinesia and involuntary movements in Parkinsons and Huntingtons diseases and dystonias. Central mechanisms of adaptation to lesions of the basal ganglia and motor pathways. Resting patterns of altered dopa and glucose metabolism and receptor binding underlying idiopathic and genetic forms of Parkinsons disease, atypical parkinsonian disorders, and involuntary movement disorders The glial response to cortical and subcortical neurodegenerations. Levels of abnormal protein aggregation (beta amyloid, tau, synuclein deposition) in cortical and subcortical dementias. Using PET as a biomarker, to determine in vivo the efficacy of: Putative neuroprotective agents in modifying progression of subcortical degenerations disorders and influencing glial activation and amyloid deposition. Nerve growth factors in restoring function in Parkinsons disease and, in the future, other subcortical neurodegenerations. Cell implants (fetal midbrain and striatal/retinal pigment epithelial/carotid body/transformed fibroblasts/neural progenitor) in restoring function in Parkinsons and Huntingtons diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1993-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>13336146</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>Huntington's Study</gtr:description><gtr:id>63A265F7-ABAD-4D17-818D-CC26B3F4FA8F</gtr:id><gtr:impact>Pavese et al Neurology 2008 (PMID: 19853661), Tai et al Brain 2007(PMID: 17400599), Reuter et al JNNP 2008 (PMID:18356253)</gtr:impact><gtr:outcomeId>4F8B42C424A-1</gtr:outcomeId><gtr:partnerContribution>Supplied patients for Research Project resulted in publication Pavese et al Neurology 2008 (PMID: 19853661), Tai et al Brain 2007(PMID: 17400599), Reuter et al JNNP 2008 (PMID:18356253)Supplied the patients for the project</gtr:partnerContribution><gtr:piContribution>We performed the PET scans on the subjects for this study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Neurosciences</gtr:department><gtr:description>Huntington's Study</gtr:description><gtr:id>4D377EDB-F35D-4F64-8219-3EBC544E4696</gtr:id><gtr:impact>Pavese et al Neurology 2008 (PMID: 19853661), Tai et al Brain 2007(PMID: 17400599), Reuter et al JNNP 2008 (PMID:18356253)</gtr:impact><gtr:outcomeId>4F8B42C424A-2</gtr:outcomeId><gtr:partnerContribution>Supplied patients for Research Project resulted in publication Pavese et al Neurology 2008 (PMID: 19853661), Tai et al Brain 2007(PMID: 17400599), Reuter et al JNNP 2008 (PMID:18356253)Supplied the patients for the project</gtr:partnerContribution><gtr:piContribution>We performed the PET scans on the subjects for this study.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Frenchay Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GDNF study</gtr:description><gtr:id>AD60C540-61F6-4C74-98A0-B75BAC329E47</gtr:id><gtr:impact>PMID: 16015352; PMID: 12669033;PMID:16429411</gtr:impact><gtr:outcomeId>EE027C5B1F1-1</gtr:outcomeId><gtr:partnerContribution>Supplied patients for our GDNF study with resulted in publications Annal of Neurology 2006, Lang et al</gtr:partnerContribution><gtr:piContribution>As above.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F08CD106-74B6-4650-86B3-448F41DFCDE0</gtr:id><gtr:impact>Question and answer and discussions followed.

Invited to give talks.</gtr:impact><gtr:outcomeId>54633c648d4f58.09250030</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What is Parkinson's disease Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F00B174E-44B6-4D4D-BC08-997CC3813D01</gtr:id><gtr:impact>What is Parkinson's Disease, London October 2011
- Small closed meeting with experts representing different aspects of Parkinson's Disease and members of the Parkinson's Disease Society (UK)

Presentations, discussions and Consensus agreed by the end of the day to publish output</gtr:impact><gtr:outcomeId>Kep2YvdwdUQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Interest (PPMI study)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F489F197-38A2-4675-A2D2-FB3DF9F690D0</gtr:id><gtr:impact>Increased interest and enquiry in our research.

People volunteering for our research.</gtr:impact><gtr:outcomeId>5463367f1a7844.00731373</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Movement Matters - PD Awareness</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8CC4325-9222-46DE-8BCF-5727AA84127D</gtr:id><gtr:impact>Web Chat lasted for more than an hour.

Invited to give presentation.</gtr:impact><gtr:outcomeId>5463378b5f88d7.51189499</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Overseas Charity - MJFF</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:fundingRef>PPMI (P34459)</gtr:fundingRef><gtr:id>149D2CF0-8295-4DC8-8926-BF6489A2D83A</gtr:id><gtr:outcomeId>5461e0dfa8a594.95799462</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>229517</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant (CHDI)/Cure Huntington's Disease Initiative (USA)</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>CHDI Foundation</gtr:fundingOrg><gtr:fundingRef>A-2987  (P26870)</gtr:fundingRef><gtr:id>B5C126DD-8DB1-45BD-B561-E7DFF5BF131B</gtr:id><gtr:outcomeId>EVH1Dcs8Mty0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>194602</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Themed Research (PDS)</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:fundingRef>AG/SS/072212  (P14798)</gtr:fundingRef><gtr:id>F2DDB16A-B538-40CC-B134-2F60E35B77C6</gtr:id><gtr:outcomeId>E72501B17D40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>249688</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Overseas Charity - MJFF</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:fundingRef>P36587</gtr:fundingRef><gtr:id>A51A0ADD-8D12-44EC-8D5D-F06965570FE7</gtr:id><gtr:outcomeId>ZbLxdCVMbr1</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220820</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>NIHR Imperial biomedical Research Centre(BRC)Funding Award</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:fundingRef>P45827</gtr:fundingRef><gtr:id>8423FD3E-937E-4141-A75D-144E463D0123</gtr:id><gtr:outcomeId>fZuLeoWN7cX</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>288719</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Michael J Fox Foundation, Clinical Discovery Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Michael J Fox Foundation</gtr:fundingOrg><gtr:fundingRef>07/H0707/133 (P14104)</gtr:fundingRef><gtr:id>37C17ECE-536B-4FF9-8A5E-D25F6986E15B</gtr:id><gtr:outcomeId>BE1DC43B4350</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>18000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>NIHR (BRC) Pilot Project Competition</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F54D0255-C094-4DEC-86AE-2E608D08E2A1</gtr:id><gtr:outcomeId>KTH1nx9Tssf</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>966000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TRANSEURO Innovative Approach for the Treatment of Parkinson's Disease (12m euros across 14 participants)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>(P22886)</gtr:fundingRef><gtr:id>8BC576C7-DDB2-4984-94E3-7C9765B68579</gtr:id><gtr:outcomeId>k3oLN9a2U8Z0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>370655</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>2009 ART Major Project Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ART-PG2009-1 (P23750)</gtr:fundingRef><gtr:id>44760937-3DBA-4707-A3D8-FA8F89B5DB82</gtr:id><gtr:outcomeId>KCd24xNQJzo0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0629B136-0231-48CE-B1E5-64EFCAAAA915</gtr:id><gtr:title>Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9846543db4183f5f0ccf80c6f934e416"><gtr:id>9846543db4183f5f0ccf80c6f934e416</gtr:id><gtr:otherNames>Yarnall AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54579449418da3.39964069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E412EDB8-380E-4790-B5C2-93EACEB53885</gtr:id><gtr:title>A? Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf1083602d4547ffbd2dfd5c62dabaf7"><gtr:id>bf1083602d4547ffbd2dfd5c62dabaf7</gtr:id><gtr:otherNames>Villemagne VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_15128_28_22218879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB3D9198-09BD-4503-826A-1C3153C37C9A</gtr:id><gtr:title>Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49d1ebc4c13ad82ac9c46d6d8f88adf6"><gtr:id>49d1ebc4c13ad82ac9c46d6d8f88adf6</gtr:id><gtr:otherNames>Tomasi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>VnH3jgJc5At</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA7B1AD8-41B6-49D3-A520-B131B988C68A</gtr:id><gtr:title>Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>339C966D3F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD29E15A-A6C5-4FB3-B1D1-9386E784570F</gtr:id><gtr:title>Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03536d1f746ea28b71a52e8aece6bfc3"><gtr:id>03536d1f746ea28b71a52e8aece6bfc3</gtr:id><gtr:otherNames>Sawamoto N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>73C22FE1B74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B680F4E-7DDF-402E-A9F4-025BAD2D3D09</gtr:id><gtr:title>Dyskinesias after transplantation in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56b4b3375dc2e7.40854035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C957CE0-3756-4890-9E6C-853100E4021F</gtr:id><gtr:title>Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a4fd269f8a153aaa555e0c7be89dc0c"><gtr:id>1a4fd269f8a153aaa555e0c7be89dc0c</gtr:id><gtr:otherNames>O'Sullivan SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b4aec0df0e87.39587996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1B74716-FA6F-4207-95CC-A69CD93BB6F9</gtr:id><gtr:title>The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5569c761d204c6033a9730736dccfe4c"><gtr:id>5569c761d204c6033a9730736dccfe4c</gtr:id><gtr:otherNames>Barker RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15128_28_23345280</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C268164-992E-4B49-BDA9-9ECCF9AA6641</gtr:id><gtr:title>Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>kcVpRgPkEeJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFEF58FC-1FE1-48DD-863D-ACBC93FB2316</gtr:id><gtr:title>Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>FC49858C035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2AF7FBE-73B4-4D50-BE6D-519222AC766C</gtr:id><gtr:title>Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd26b1e138b12e934f0f4bc35f2a04be"><gtr:id>cd26b1e138b12e934f0f4bc35f2a04be</gtr:id><gtr:otherNames>Nombela C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>545782607adff1.88681935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBD22B16-B3FE-4970-8D32-1BEFB4EAC5F5</gtr:id><gtr:title>Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.</gtr:title><gtr:parentPublicationTitle>Human brain mapping</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1065-9471</gtr:issn><gtr:outcomeId>56b375ebe5e960.03663638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3A551F2-DC32-4692-936C-1FE39D20B29B</gtr:id><gtr:title>Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9e4eddf03a829de08143c698793a462"><gtr:id>c9e4eddf03a829de08143c698793a462</gtr:id><gtr:otherNames>Scherfler C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>D34D6BEF3B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59762682-A6AB-4427-855F-3F493BC05A95</gtr:id><gtr:title>Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9e4eddf03a829de08143c698793a462"><gtr:id>c9e4eddf03a829de08143c698793a462</gtr:id><gtr:otherNames>Scherfler C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56b4b1e41fc730.91522191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F97C8F2-8CA2-45E1-A3C4-46282523E16D</gtr:id><gtr:title>Imaging microglial activation in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Brain research bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0a8b16aa776f53413c2aa9f59b14c3"><gtr:id>fb0a8b16aa776f53413c2aa9f59b14c3</gtr:id><gtr:otherNames>Tai YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0361-9230</gtr:issn><gtr:outcomeId>DBAEE012915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D1A47D7-E168-456A-9E98-214198477E26</gtr:id><gtr:title>Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d5ff3112eb4c8114965fb4425fcde55"><gtr:id>9d5ff3112eb4c8114965fb4425fcde55</gtr:id><gtr:otherNames>Duncan GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>545799fa8f29e5.56154283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDC24832-8102-4C5D-971B-C84964B773B1</gtr:id><gtr:title>Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b37843e886f4.48025750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EEAECE6-B5BE-4D70-A2A5-DDD0E0D298D7</gtr:id><gtr:title>Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>KTcxwfLhFLU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46311CF0-8129-4FD7-829E-577CD23CCD0F</gtr:id><gtr:title>Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34db3cca61c705ef16e032e1c61a9964"><gtr:id>34db3cca61c705ef16e032e1c61a9964</gtr:id><gtr:otherNames>Martinez-Martin P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15128_28_22237822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C4C3AD5-6E73-4D78-A10F-09737EDEC5E2</gtr:id><gtr:title>Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e0f333502ce44c85b0ee264bbf20970"><gtr:id>1e0f333502ce44c85b0ee264bbf20970</gtr:id><gtr:otherNames>Loane C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15128_28_23596065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>480C70FD-35DD-4E46-9C1A-35F5842E7D5E</gtr:id><gtr:title>Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid ?-amyloid 42: a cross-validation study against amyloid positron emission tomography.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f172ca51b3e5d44d83d1009531076e19"><gtr:id>f172ca51b3e5d44d83d1009531076e19</gtr:id><gtr:otherNames>Palmqvist S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5457984bd65c38.85080321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>411F96CD-11AF-4A67-A5D9-8E59E5D339B0</gtr:id><gtr:title>Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>CyYYbxPZikW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB07C79B-54BC-44D2-BD97-0002D17622E1</gtr:id><gtr:title>Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c125bf00e8b99982bcddb77b4bf18c4"><gtr:id>9c125bf00e8b99982bcddb77b4bf18c4</gtr:id><gtr:otherNames>Watson BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>5457a035cf6e61.42268131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8219336-5F2D-470C-9530-2F316192CA6C</gtr:id><gtr:title>Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/124f357c98a033f3912a64573f57c123"><gtr:id>124f357c98a033f3912a64573f57c123</gtr:id><gtr:otherNames>Goerendt IK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b4b42d825967.84088231</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5ACAD4C4-178B-41D0-9EB6-B602ADE48C74</gtr:id><gtr:title>Dopamine transporter: basic aspects and neuroimaging.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dcd09e0bdafa3d5cf3afe2317758b82"><gtr:id>9dcd09e0bdafa3d5cf3afe2317758b82</gtr:id><gtr:otherNames>Piccini PP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56b4b30a681c22.62907401</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B5C6C59-BA04-4518-A9AD-455040644201</gtr:id><gtr:title>Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>F557C33274F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1FC49DE-4FA3-4A77-8006-3D47A07D8343</gtr:id><gtr:title>Neuroprotection and imaging studies in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>EyNvszPnUdB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A325FE19-1337-4494-AF5E-A36BE1030788</gtr:id><gtr:title>Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>pm_15128_28_22491951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4E50B3F-C0D9-4A77-B6A3-448529FD9AC4</gtr:id><gtr:title>Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b0927d5f1db5.08084347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E509EA59-9CEF-4199-B91F-CF53B11F084E</gtr:id><gtr:title>Plasticity of the nigropallidal pathway in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31679f881a62336b67fd1cf81af6f293"><gtr:id>31679f881a62336b67fd1cf81af6f293</gtr:id><gtr:otherNames>Whone AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56b4b405794408.64194607</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CDDF1AB-B530-49F4-B616-73A4386411D3</gtr:id><gtr:title>Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47adce141336e8a72143ae842018daeb"><gtr:id>47adce141336e8a72143ae842018daeb</gtr:id><gtr:otherNames>Archer HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>4318E77CD25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A32CF3-A86F-4583-88E8-7819F7F93A6C</gtr:id><gtr:title>Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eeebeaa623a1644c5fee34b914c47435"><gtr:id>eeebeaa623a1644c5fee34b914c47435</gtr:id><gtr:otherNames>Sperling R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_15128_28_22305802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49128EC6-260A-4663-A10B-12D8F9E2ABF7</gtr:id><gtr:title>Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bd811a5fe1bfd6f608c2b2af9425977"><gtr:id>6bd811a5fe1bfd6f608c2b2af9425977</gtr:id><gtr:otherNames>Ahmed I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>XGH4K5ohYMV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B09BE53C-FBBC-477B-BA77-4A5CEA38CC78</gtr:id><gtr:title>Microglial activation correlates with severity in Huntington disease: a clinical and PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>DE587E4D2AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD56C4C2-6233-435A-9117-8B87AE5C07D4</gtr:id><gtr:title>Cortical 5-HT1A receptor binding in patients with homozygous D90A SOD1 vs sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>1672392E5EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED1435BC-D5A6-4D2C-9683-869A3293A98D</gtr:id><gtr:title>Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_15128_28_23303049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E82A1B17-14CB-48FB-A381-62DBFE03307C</gtr:id><gtr:title>Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: an in vivo 11C-raclopride PET study.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>A34A53A1895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A70D3344-F845-46B0-91BE-667CB1C4CDAD</gtr:id><gtr:title>Distributed neural actions of anti-parkinsonian therapies as revealed by PET.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/124f357c98a033f3912a64573f57c123"><gtr:id>124f357c98a033f3912a64573f57c123</gtr:id><gtr:otherNames>Goerendt IK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>3B2D1534296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17577D8E-FBB2-4236-A268-8D3C5D913EFD</gtr:id><gtr:title>Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>463A355F0C1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C33A74A8-DAA8-4875-8E60-F738B888DEE8</gtr:id><gtr:title>Inflammation after trauma: microglial activation and traumatic brain injury.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42c260a1010cc3d69d7c9083ccd7eadc"><gtr:id>42c260a1010cc3d69d7c9083ccd7eadc</gtr:id><gtr:otherNames>Ramlackhansingh AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pEG7Bdd4bd1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85142FE8-3D9B-47B1-AEF9-D93F7F18683E</gtr:id><gtr:title>Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa465c7cf5ea8070eb29ebd0e5f4bc03"><gtr:id>aa465c7cf5ea8070eb29ebd0e5f4bc03</gtr:id><gtr:otherNames>Khan NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56b4b2370ea1b1.03120117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87E59E25-1DF3-49AF-9235-2DFDFF683F32</gtr:id><gtr:title>An early and late peak in microglial activation in Alzheimer's disease trajectory.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5a8ff4bc2ea755.00160975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A9DFD47-482A-4199-B4F1-5FF34B28DA67</gtr:id><gtr:title>Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d3971451316f7135b5932a7de43672"><gtr:id>d3d3971451316f7135b5932a7de43672</gtr:id><gtr:otherNames>Garvey LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>pm_15128_28_23887068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1FA87C8-A442-4D69-A825-1E2FEBC7B3C6</gtr:id><gtr:title>Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d44f0ab5d81d4ac2378df857ebedd6c"><gtr:id>8d44f0ab5d81d4ac2378df857ebedd6c</gtr:id><gtr:otherNames>Mariani JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>pm_15128_28_22795453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8F62DB2-4BEA-4061-96EA-22D21025F2FC</gtr:id><gtr:title>Binary classification of &amp;sup1;8F-flutemetamol PET using machine learning: comparison with visual reads and structural MRI.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94cf9572067b4b86455e1ad03f211e12"><gtr:id>94cf9572067b4b86455e1ad03f211e12</gtr:id><gtr:otherNames>Vandenberghe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15128_28_22982358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>720919EE-C95C-4F7B-B0F5-859010308D70</gtr:id><gtr:title>Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ce6eeacfdcd5222747dab3fa256a93b"><gtr:id>1ce6eeacfdcd5222747dab3fa256a93b</gtr:id><gtr:otherNames>Love S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>9C348EC2EAD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35383960-79C5-4ABA-A788-3D0C0D7067CE</gtr:id><gtr:title>Brain shaving: adaptive detection for brain PET data.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cb0d60f369b32844de70d46a1968ba59"><gtr:id>cb0d60f369b32844de70d46a1968ba59</gtr:id><gtr:otherNames>Grecchi E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn><gtr:outcomeId>5457a57a8925e9.28879798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>671EF69B-1529-458E-9735-31BF4C0A7AFA</gtr:id><gtr:title>PET studies in Parkinson's disease motor and cognitive dysfunction.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>pm_15128_28_22166468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB174201-933E-442C-BD16-505293C45061</gtr:id><gtr:title>Problematic Internet use in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e1844ad97c25082d358aaa915c387d"><gtr:id>34e1844ad97c25082d358aaa915c387d</gtr:id><gtr:otherNames>Wu K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>5457a72c0efa73.71896556</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB215170-CAC0-4B32-9E41-FC007B0135AC</gtr:id><gtr:title>Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56b3772d81b225.08896763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F57B4C21-8241-467C-87CC-77FC6072F3C5</gtr:id><gtr:title>Persistent nigrostriatal dopaminergic abnormalities in ex-users of MDMA ('Ecstasy'): an 18F-dopa PET study.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0a8b16aa776f53413c2aa9f59b14c3"><gtr:id>fb0a8b16aa776f53413c2aa9f59b14c3</gtr:id><gtr:otherNames>Tai YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>56b4af45184927.23363626</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B024D893-C169-4F42-B98E-1B4ACCA4DCE9</gtr:id><gtr:title>Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b4b3be46fde1.77920338</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEE7238B-9294-4AEC-A342-A7F0B2B9107F</gtr:id><gtr:title>Positron emission tomography imaging in neurological disorders.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56b376aa10d090.92443993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>845D03DD-F637-4029-A9CE-E765200D6B45</gtr:id><gtr:title>Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>60C3FC56AAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B50142AB-2F77-4C22-8022-45F9C7C92FC4</gtr:id><gtr:title>Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab6f23445d22c4d5d17064439502b510"><gtr:id>ab6f23445d22c4d5d17064439502b510</gtr:id><gtr:otherNames>Nelissen N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>E0147843F41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B27D7198-76B1-442F-A0B5-94963EA62A1C</gtr:id><gtr:title>Thalamic inflammation after brain trauma is associated with thalamo-cortical white matter damage.</gtr:title><gtr:parentPublicationTitle>Journal of neuroinflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/071e882d6d5617fac73b55ac1d8145b1"><gtr:id>071e882d6d5617fac73b55ac1d8145b1</gtr:id><gtr:otherNames>Scott G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1742-2094</gtr:issn><gtr:outcomeId>56cc3473e6cfd1.18566514</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93876224-CAE9-419C-B3BF-13041834D092</gtr:id><gtr:title>Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd07a9b4cf0377237a98ea0d1dcf8d9"><gtr:id>1fd07a9b4cf0377237a98ea0d1dcf8d9</gtr:id><gtr:otherNames>Kefalopoulou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5457a852b8f423.78743435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECF216E1-697D-4C47-9248-5F12B11B53B4</gtr:id><gtr:title>Do we still need to develop new imaging biomarkers of dopamine denervation for Parkinson's disease?</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>pm_15128_28_22036688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DA952EF-4C31-4438-BACF-4C460AD81BAB</gtr:id><gtr:title>Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5a8ff5921604c9.80623445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62C70F32-7125-4A18-8F70-92C52BB7442B</gtr:id><gtr:title>Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15128_28_22306804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2BFA375-D0B2-4164-B6D2-DF4997F8AF8B</gtr:id><gtr:title>Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>D9F33DAFE2F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>362D6C84-348B-469A-8E28-B08A97914F29</gtr:id><gtr:title>Dystonia: hopes for a better diagnosis and a treatment with long-lasting effect.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15128_28_23436501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31EB18AD-012B-4AF7-91FC-1E5F6DEAA50C</gtr:id><gtr:title>Brain imaging after neural transplantation.</gtr:title><gtr:parentPublicationTitle>Progress in brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0079-6123</gtr:issn><gtr:outcomeId>56b3756ef0b618.82535414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64331DC9-8B37-4E84-9B90-49B4ADDE60E7</gtr:id><gtr:title>Reference and target region modeling of [11C]-(R)-PK11195 brain studies.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6388bd935e8af8c0bb4d3186f2a3278a"><gtr:id>6388bd935e8af8c0bb4d3186f2a3278a</gtr:id><gtr:otherNames>Turkheimer FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>7AE5FC2508F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F131813-FF45-48A3-A865-0B0743401A50</gtr:id><gtr:title>Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls.</gtr:title><gtr:parentPublicationTitle>Experimental and clinical psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef17385a603824537fcff59a18f447b"><gtr:id>aef17385a603824537fcff59a18f447b</gtr:id><gtr:otherNames>Hoshi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1064-1297</gtr:issn><gtr:outcomeId>5A33BCA7980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D32A432-B4F5-4624-8C4D-4C533BEB6DFB</gtr:id><gtr:title>Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ed340a76e0a045e6532fee85138ebb1"><gtr:id>9ed340a76e0a045e6532fee85138ebb1</gtr:id><gtr:otherNames>Giannetti P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>5457a7f65b5364.13607074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB79AD45-4C18-433A-8C93-53EE66B66ED5</gtr:id><gtr:title>Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-na&amp;iuml;ve controls.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef17385a603824537fcff59a18f447b"><gtr:id>aef17385a603824537fcff59a18f447b</gtr:id><gtr:otherNames>Hoshi R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>E08948F0045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DB9D85C-C0EB-4088-8691-520DBA6040E6</gtr:id><gtr:title>Hypothalamic involvement in Huntington's disease: an in vivo PET study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b4a1e5c95647.41038885</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA7F96E-F6D8-4C1E-84D0-E67F59D95457</gtr:id><gtr:title>Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>5a8ff90017ea60.30446474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31A7AF7D-DE69-46BA-84F2-5D8992A23089</gtr:id><gtr:title>Imaging of microglia in patients with neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Frontiers in pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1663-9812</gtr:issn><gtr:outcomeId>56b376efb25752.99692171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAF1D2AC-1735-49F3-BED4-D352780FA189</gtr:id><gtr:title>Functional brain imaging in the differential diagnosis of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>56b4b29ae637e4.38663005</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8703216D-3455-4589-9EF7-B43CE8500F9B</gtr:id><gtr:title>Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>mfLsQVrhkfL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B402CE-E04E-4A6D-A0E6-55D812CA9E72</gtr:id><gtr:title>Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d3971451316f7135b5932a7de43672"><gtr:id>d3d3971451316f7135b5932a7de43672</gtr:id><gtr:otherNames>Garvey LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15128_28_22808022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>744D46BF-DC98-4DAD-A0E9-80A6EF668586</gtr:id><gtr:title>Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cb92c6853ac7d62b0aa1cf1e9071d38"><gtr:id>8cb92c6853ac7d62b0aa1cf1e9071d38</gtr:id><gtr:otherNames>M?nguez-Castellanos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>0BE161A47DC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FFB5A1A-899C-4D26-9EB1-E7A124EE5FB0</gtr:id><gtr:title>Imaging non-dopaminergic function in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc39481bfb591a878dc808e943f2de8"><gtr:id>9bc39481bfb591a878dc808e943f2de8</gtr:id><gtr:otherNames>Brooks DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1536-1632</gtr:issn><gtr:outcomeId>57FBD55A082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB0EE60A-2D27-41BE-A7C7-8FD317833DAF</gtr:id><gtr:title>In vivo imaging of the integration and function of nigral grafts in clinical trials.</gtr:title><gtr:parentPublicationTitle>Progress in brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0079-6123</gtr:issn><gtr:outcomeId>56b377bd4baba5.73810588</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC378B8-624A-4467-8AE1-D05F272EAC23</gtr:id><gtr:title>[&amp;sup1;8F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [&amp;sup1;8F]FDOPA and [&amp;sup1;&amp;sup1;C]DASB PET study in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>TiMxLE37mkp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6135C43-6D19-4292-9C9C-C6DEC0B85D2D</gtr:id><gtr:title>Imaging the aetiology of sleep disorders in dementia and Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>5457a532b5c228.14317476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E8C4904-A7D1-4C69-877A-4F86A97CB0D4</gtr:id><gtr:title>Can imaging separate multiple system atrophy from Parkinson's disease?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc39481bfb591a878dc808e943f2de8"><gtr:id>9bc39481bfb591a878dc808e943f2de8</gtr:id><gtr:otherNames>Brooks DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15128_28_22252889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750DE368-78BA-4863-88E6-8D034C6F3505</gtr:id><gtr:title>Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25e3b2dd2d044ea4843c4fd941c54fae"><gtr:id>25e3b2dd2d044ea4843c4fd941c54fae</gtr:id><gtr:otherNames>Remy P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>71A92036A10</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B29D558-6D26-4CAB-A720-6AD919721BD3</gtr:id><gtr:title>Resting tremor in Parkinson disease: is the pallidum to blame?</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/edbb4a47ea66624208c484bd50bdfaa2"><gtr:id>edbb4a47ea66624208c484bd50bdfaa2</gtr:id><gtr:otherNames>Boecker H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>tNoRLbfVTt2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>974E0233-FA7B-47E2-8F35-C27AF945085B</gtr:id><gtr:title>Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f4b2d99a4af483389be52300323264c"><gtr:id>1f4b2d99a4af483389be52300323264c</gtr:id><gtr:otherNames>Reuter I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>FFAF30346DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9F48DB6-2B52-41D0-A82F-FD3CAA4A88AA</gtr:id><gtr:title>New developments of brain imaging for Parkinson's disease and related disorders.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56b4a2f40fe0f1.42416976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B88866F3-20A6-44A3-B654-85594B8E6555</gtr:id><gtr:title>The prognostic value of amyloid imaging.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ffdd736c5914dde52249bbba68a241c"><gtr:id>8ffdd736c5914dde52249bbba68a241c</gtr:id><gtr:otherNames>Gelosa G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_15128_28_22491780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CDD0F6D-BE32-4053-B958-25C8BC51AA70</gtr:id><gtr:title>Noninvasive molecular imaging of neuroinflammation.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21f96b19b8029ea25da5e821c63e5469"><gtr:id>21f96b19b8029ea25da5e821c63e5469</gtr:id><gtr:otherNames>Jacobs AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_15128_28_22549622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACA5B263-CE6C-41EC-8EF9-7928FB5672A5</gtr:id><gtr:title>Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729d98d63c1b27af0f8e7f4b75f5ebff"><gtr:id>729d98d63c1b27af0f8e7f4b75f5ebff</gtr:id><gtr:otherNames>Cheesman AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>18EC43A8483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2C1E1F6-9D20-4081-9A71-FFC8FDF00D7B</gtr:id><gtr:title>Neurodegenerative movement disorders: the contribution of functional imaging.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>56b4b2682ab717.61264170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41543A44-BAC4-4436-AF5A-C1F145A91241</gtr:id><gtr:title>Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad20b0affb1ad067d0c89b85c200083e"><gtr:id>ad20b0affb1ad067d0c89b85c200083e</gtr:id><gtr:otherNames>Grover VP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>pm_15128_28_22239531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47BA35F5-345B-47DB-B63B-F74A113039F5</gtr:id><gtr:title>Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81855b535a39825ae698d2f4b40d6816"><gtr:id>81855b535a39825ae698d2f4b40d6816</gtr:id><gtr:otherNames>Lang AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>AD3D59EEDBF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D527FFD8-D408-4286-86E6-F6E21F839CBB</gtr:id><gtr:title>Imaging of genetic and degenerative disorders primarily causing Parkinsonism.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc39481bfb591a878dc808e943f2de8"><gtr:id>9bc39481bfb591a878dc808e943f2de8</gtr:id><gtr:otherNames>Brooks DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>5a8ff6501df6f9.20768287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4178120B-4269-4F5A-A676-D52A1E66143B</gtr:id><gtr:title>Dyskinesias following neural transplantation in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f012bdda027f571b3a4b48c24756cc40"><gtr:id>f012bdda027f571b3a4b48c24756cc40</gtr:id><gtr:otherNames>Hagell P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56b4b4af47d275.53861527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57216122-17C1-4539-B137-37A7C3701757</gtr:id><gtr:title>Amyloid pathology and axonal injury after brain trauma.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/071e882d6d5617fac73b55ac1d8145b1"><gtr:id>071e882d6d5617fac73b55ac1d8145b1</gtr:id><gtr:otherNames>Scott G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a8ff7b66134e5.99030161</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A17A88F-E9D9-4884-84E8-4BB3401404DB</gtr:id><gtr:title>Sleep disturbance and impulsive-compulsive behaviours in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a4fd269f8a153aaa555e0c7be89dc0c"><gtr:id>1a4fd269f8a153aaa555e0c7be89dc0c</gtr:id><gtr:otherNames>O'Sullivan SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56b4a119a34029.05993594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11B754A6-6C25-4D45-BDA1-B872745C79F6</gtr:id><gtr:title>Cortico-striatal activation during implicit sequence learning in Parkinson's disease with deep brain stimulation of the subthalamic nucleus</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9021a2c942a1f85ea4926fe09b25602"><gtr:id>e9021a2c942a1f85ea4926fe09b25602</gtr:id><gtr:otherNames>Jahanshahi M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>31F8047DD58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF2C617F-3696-4D17-A389-DAD70DFB4757</gtr:id><gtr:title>Serotonergic mediated body mass index changes in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56b4ae571bca61.79767736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D944A6E-F360-4620-8D00-F7EEC19441A6</gtr:id><gtr:title>STN stimulation alters pallidal-frontal coupling during response selection under competition.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9d9e1008aec68feac8ac553306dff68"><gtr:id>f9d9e1008aec68feac8ac553306dff68</gtr:id><gtr:otherNames>Thobois S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>FD8E91A9FE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9B42F40-808B-40A5-8184-60A7F7B2DC14</gtr:id><gtr:title>Probabilistic classification learning with corrective feedback is associated with in vivo striatal dopamine release in the ventral striatum, while learning without feedback is not.</gtr:title><gtr:parentPublicationTitle>Human brain mapping</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c450255674dc0a6616e7a7b823433e9"><gtr:id>9c450255674dc0a6616e7a7b823433e9</gtr:id><gtr:otherNames>Wilkinson L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1065-9471</gtr:issn><gtr:outcomeId>5457a6eaed5132.98962475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>084EF964-15E1-41B0-AB4C-002DDC8769C2</gtr:id><gtr:title>Impaired recognition of facial expressions of anger in Parkinson's disease patients acutely withdrawn from dopamine replacement therapy.</gtr:title><gtr:parentPublicationTitle>Neuropsychologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45218aeab033c3c90fad61b79a102255"><gtr:id>45218aeab033c3c90fad61b79a102255</gtr:id><gtr:otherNames>Lawrence AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3932</gtr:issn><gtr:outcomeId>708F53B1497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6A3EA7-9C22-4989-8383-72880F4AB115</gtr:id><gtr:title>DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13edf8b31051bff6cc4b8f33e86ff4e2"><gtr:id>13edf8b31051bff6cc4b8f33e86ff4e2</gtr:id><gtr:otherNames>Lippa CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>0BA215F2E6D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE6990A8-ECA8-4D9F-82E4-5F5BBF2E70EE</gtr:id><gtr:title>11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>ZaNCAqaXFDL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96F1355-9FA7-40EB-9F2D-2C5F9C105A64</gtr:id><gtr:title>Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa465c7cf5ea8070eb29ebd0e5f4bc03"><gtr:id>aa465c7cf5ea8070eb29ebd0e5f4bc03</gtr:id><gtr:otherNames>Khan NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>2DBA7B76697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F548EF7-9D10-4BD0-AE78-44D17246793A</gtr:id><gtr:title>In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93565756ed2888e7ac0ef7ac77289f14"><gtr:id>93565756ed2888e7ac0ef7ac77289f14</gtr:id><gtr:otherNames>Gerhard A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>68382C4EE88</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C18EDB2-2888-4FED-82BF-E82063469D85</gtr:id><gtr:title>Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting--A retrospective analysis of [(15)O]H(2)O PET-CBF studies in 65 patients.</gtr:title><gtr:parentPublicationTitle>Clinical neurology and neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03ffdb70a848463b2e49aa2d5ecafccb"><gtr:id>03ffdb70a848463b2e49aa2d5ecafccb</gtr:id><gtr:otherNames>Klinge PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0303-8467</gtr:issn><gtr:outcomeId>B51A5BCF334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3886CCD5-5F30-4DA9-BE5F-0AEB674699F5</gtr:id><gtr:title>Quantification of opioid receptor availability following spontaneous epileptic seizures: correction of [11C]diprenorphine PET data for the partial-volume effect.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e93cb976d5a49cb87347c23237e107a5"><gtr:id>e93cb976d5a49cb87347c23237e107a5</gtr:id><gtr:otherNames>McGinnity CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_15128_28_23597934</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>274BD198-CDD0-4A24-8582-0E4F45A1C50C</gtr:id><gtr:title>Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4785fe51a7f54fbcebf09629bc5a0bcb"><gtr:id>4785fe51a7f54fbcebf09629bc5a0bcb</gtr:id><gtr:otherNames>Thurfjell L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>pm_15128_28_22301718</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0E85998-9CF5-4DEA-A3A5-4A97961EA93D</gtr:id><gtr:title>Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>musCLXT7rzP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35FFC83F-03BD-4F9C-B19C-30ABE4BBA769</gtr:id><gtr:title>Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in psychology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45218aeab033c3c90fad61b79a102255"><gtr:id>45218aeab033c3c90fad61b79a102255</gtr:id><gtr:otherNames>Lawrence AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-1078</gtr:issn><gtr:outcomeId>pm_15128_28_23450713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFED363B-71F6-4AB2-A280-5420AEE2DE87</gtr:id><gtr:title>The catechol-O-methyltransferase Val(158)Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson's disease: a PET study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34e1844ad97c25082d358aaa915c387d"><gtr:id>34e1844ad97c25082d358aaa915c387d</gtr:id><gtr:otherNames>Wu K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15128_28_22843413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B531126A-822B-4ECE-AAE5-9CDD25F7FF99</gtr:id><gtr:title>Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>CCFD271E038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>433BEA8A-8057-45C5-A87F-3125842DE57A</gtr:id><gtr:title>In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93565756ed2888e7ac0ef7ac77289f14"><gtr:id>93565756ed2888e7ac0ef7ac77289f14</gtr:id><gtr:otherNames>Gerhard A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>597AC526461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E662148B-8841-4C43-8674-995F1D84792C</gtr:id><gtr:title>Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>7C56F132F10</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>440586E4-A95C-4DEC-82BB-C2A603039D88</gtr:id><gtr:title>Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>A2A343CAF0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2F144F3-51C0-4A92-8F40-D790F21217A2</gtr:id><gtr:title>Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>5457975dbc14e2.30217987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>925D5345-3B2E-49DD-9354-26868A01226F</gtr:id><gtr:title>Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61d65f17a4baf6b87d0ce6fc92c5f496"><gtr:id>61d65f17a4baf6b87d0ce6fc92c5f496</gtr:id><gtr:otherNames>Koole M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>A105AD00B66</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35B48DA9-0B71-45F9-B261-E572686CA45E</gtr:id><gtr:title>Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>188F3ACA9F1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CA212C5-E567-4361-AA89-6EFC0162F66F</gtr:id><gtr:title>In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>mZ5nz7EHFGz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F590FFBC-9213-4360-80C1-FB09DCE6B4AB</gtr:id><gtr:title>Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa465c7cf5ea8070eb29ebd0e5f4bc03"><gtr:id>aa465c7cf5ea8070eb29ebd0e5f4bc03</gtr:id><gtr:otherNames>Khan NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56b4b459deb9c8.18717822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>631CDD95-3C75-430E-A36C-12CBE97322C0</gtr:id><gtr:title>PET image denoising using a synergistic multiresolution analysis of structural (MRI/CT) and functional datasets.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6388bd935e8af8c0bb4d3186f2a3278a"><gtr:id>6388bd935e8af8c0bb4d3186f2a3278a</gtr:id><gtr:otherNames>Turkheimer FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>56b4a2661097e6.52998065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A8DFEB3-8E52-4DF2-9CB8-99E93B7161BD</gtr:id><gtr:title>(11)C-PIB PET in subjective cognitive impairment.</gtr:title><gtr:parentPublicationTitle>European psychiatry : the journal of the Association of European Psychiatrists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba819c516fec5c273c4647ca9113560"><gtr:id>1ba819c516fec5c273c4647ca9113560</gtr:id><gtr:otherNames>Rodda J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0924-9338</gtr:issn><gtr:outcomeId>gJNSVgmvJmT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>105FE9CC-8CF8-4D75-A260-07850E644F03</gtr:id><gtr:title>Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b8bfbbf7c5f9349931d4f38f3cbde2"><gtr:id>06b8bfbbf7c5f9349931d4f38f3cbde2</gtr:id><gtr:otherNames>Taylor S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>5a8ff777bef277.23597722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98E35B67-6834-4305-A606-2F6384AA91D7</gtr:id><gtr:title>Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd6b47e5a50a1922a22eb25838e6d775"><gtr:id>fd6b47e5a50a1922a22eb25838e6d775</gtr:id><gtr:otherNames>Clark L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>56b37776457115.94446463</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB7BAC9D-DCB5-4D4D-8DDA-E8E47AFD3879</gtr:id><gtr:title>A proposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/428d3ee9f640b47898ff102ea5cdfabd"><gtr:id>428d3ee9f640b47898ff102ea5cdfabd</gtr:id><gtr:otherNames>Ray Chaudhuri K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15128_28_23468940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B18D522D-6818-41FB-9689-8E9869856ABA</gtr:id><gtr:title>Imaging in Parkinson's disease: the role of monoamines in behavior.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc39481bfb591a878dc808e943f2de8"><gtr:id>9bc39481bfb591a878dc808e943f2de8</gtr:id><gtr:otherNames>Brooks DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>56b4afdbd13217.52728269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>398364CD-D7FE-439E-B090-880A97873B7F</gtr:id><gtr:title>Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [&amp;sup1;&amp;sup1;C]MePPEP.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e18ed6830ef0bda04ab664550f014ef"><gtr:id>0e18ed6830ef0bda04ab664550f014ef</gtr:id><gtr:otherNames>Ria?o Barros DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>545798951ba573.36074678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25D6C3C5-3368-49D9-9F15-C616D92FE62D</gtr:id><gtr:title>Cardiovascular effects of methamphetamine in Parkinson's disease patients.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56b4b2d92ebb85.92808840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE7D5066-F6AF-4CA6-9E9B-8D754B5A6DB5</gtr:id><gtr:title>Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a767a06c845d5b1c319dde82769708c"><gtr:id>0a767a06c845d5b1c319dde82769708c</gtr:id><gtr:otherNames>Hu MT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>73F9798D625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB554886-3840-40C0-90AE-284B7040795F</gtr:id><gtr:title>Compulsive drug use linked to sensitized ventral striatal dopamine transmission.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ce3aaefefa9b6e17ea770337d54490e"><gtr:id>8ce3aaefefa9b6e17ea770337d54490e</gtr:id><gtr:otherNames>Evans AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>4393BDF1197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B3F6B60-1A63-4A35-A3CF-1A0F138CE16D</gtr:id><gtr:title>Reversing the polarity of bipolar stimulation in deep brain stimulation for essential tremor: a theoretical explanation for a useful clinical intervention.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2758b809c25b240b1178df52fdc91302"><gtr:id>2758b809c25b240b1178df52fdc91302</gtr:id><gtr:otherNames>Yousif N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>pm_15128_28_23003326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6330D6F3-F5F7-4A23-BDAF-1977FA4501ED</gtr:id><gtr:title>Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>54579412816a74.68692348</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90F7C0AA-4EB9-464D-BF1C-0BAE221E4A5F</gtr:id><gtr:title>Diffusion-weighted imaging and its relationship to microglial activation in parkinsonian syndromes.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9be49eefc2150e1f0bb017706484ad7"><gtr:id>f9be49eefc2150e1f0bb017706484ad7</gtr:id><gtr:otherNames>Kobylecki C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>pm_15128_28_23425503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB2E7D06-F683-45F9-93E4-B5860A05A264</gtr:id><gtr:title>Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study.</gtr:title><gtr:parentPublicationTitle>Journal of neural transmission (Vienna, Austria : 1996)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0a8b16aa776f53413c2aa9f59b14c3"><gtr:id>fb0a8b16aa776f53413c2aa9f59b14c3</gtr:id><gtr:otherNames>Tai YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-9564</gtr:issn><gtr:outcomeId>797659D78CE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>884DD55A-F451-4219-9E35-7F2C0A9E0BA1</gtr:id><gtr:title>Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa465c7cf5ea8070eb29ebd0e5f4bc03"><gtr:id>aa465c7cf5ea8070eb29ebd0e5f4bc03</gtr:id><gtr:otherNames>Khan NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b4b48225a280.94365441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0882443D-8761-4C36-AC0B-5ECB33363045</gtr:id><gtr:title>PET Imaging in Huntington's Disease.</gtr:title><gtr:parentPublicationTitle>Journal of Huntington's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72effebdece862631d14369ee61bcd2c"><gtr:id>72effebdece862631d14369ee61bcd2c</gtr:id><gtr:otherNames>Roussakis AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1879-6397</gtr:issn><gtr:outcomeId>56b4a3af2c1fc6.22842959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6356F23-4917-42B8-BBCE-A19D83447791</gtr:id><gtr:title>Spatiotemporal visualization of deep brain stimulation-induced effects in the subthalamic nucleus.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2758b809c25b240b1178df52fdc91302"><gtr:id>2758b809c25b240b1178df52fdc91302</gtr:id><gtr:otherNames>Yousif N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>pm_15128_28_22805069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF9ECF65-8808-4695-BE96-EFBAEE79B122</gtr:id><gtr:title>Combined pedunculopontine-subthalamic stimulation in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f866ece9ee13c82de8b8a205ee4b33b2"><gtr:id>f866ece9ee13c82de8b8a205ee4b33b2</gtr:id><gtr:otherNames>Khan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15128_28_22402859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F46B5AAB-6B38-4502-8B34-5BBA00841DFC</gtr:id><gtr:title>Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49d1ebc4c13ad82ac9c46d6d8f88adf6"><gtr:id>49d1ebc4c13ad82ac9c46d6d8f88adf6</gtr:id><gtr:otherNames>Tomasi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>2E869BBB0DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3D0D99E-4C71-4E8E-BB2A-E2B686C6FCFC</gtr:id><gtr:title>Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06b2a4b66e62d1acb54d2d19da88c8da"><gtr:id>06b2a4b66e62d1acb54d2d19da88c8da</gtr:id><gtr:otherNames>Ros R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>A6B897BD964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D0D6715-8B97-4265-BFB3-4B99869ECF08</gtr:id><gtr:title>Age at onset and Parkinson disease phenotype.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3770a1d59fe1e44f8c4d4a9f4f67a424"><gtr:id>3770a1d59fe1e44f8c4d4a9f4f67a424</gtr:id><gtr:otherNames>Pagano G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a8ff7351b9885.19633329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1219D98E-6179-424C-BF0D-DB9B5560CB2D</gtr:id><gtr:title>Initial evaluation of 18F-GE-179, a putative PET Tracer for activated N-methyl D-aspartate receptors.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e93cb976d5a49cb87347c23237e107a5"><gtr:id>e93cb976d5a49cb87347c23237e107a5</gtr:id><gtr:otherNames>McGinnity CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>545798ddd110e1.26278729</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E2F2F8-F84D-43CF-A242-A3CDAB8B5061</gtr:id><gtr:title>A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba65bcf035709e784cb1af64b689809f"><gtr:id>ba65bcf035709e784cb1af64b689809f</gtr:id><gtr:otherNames>Nordberg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_15128_28_22961445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C565D2C9-BE8F-4D00-9DA7-38B19721406B</gtr:id><gtr:title>Parkinson's disease symptoms: the patient's perspective.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>JywBvB9bKCE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFA0E715-7B24-4E5B-AF6E-C3AB6B137680</gtr:id><gtr:title>Psychogenic and neural visual-cue response in PD dopamine dysregulation syndrome.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e0f333502ce44c85b0ee264bbf20970"><gtr:id>1e0f333502ce44c85b0ee264bbf20970</gtr:id><gtr:otherNames>Loane C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56b4a402a5db68.24385903</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F0EABD2-D237-4F99-A3C5-E0F1CBAECB76</gtr:id><gtr:title>Endogenous dopamine release after pharmacological challenges in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>56b4b36835f100.09707315</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31792DF6-29B6-4491-A283-1450EAD106E7</gtr:id><gtr:title>Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac842786439e217b7106b717ca6d425c"><gtr:id>ac842786439e217b7106b717ca6d425c</gtr:id><gtr:otherNames>Williams TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>F243ACE0C99</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5A0A746-7C47-4A8E-A5C4-DE8B35BE6F5C</gtr:id><gtr:title>Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90c62cf2e588e06d82be7991ac537b13"><gtr:id>90c62cf2e588e06d82be7991ac537b13</gtr:id><gtr:otherNames>Pavese N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>ZdVUEtX7iH9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0919CCA-7A1D-484C-83FE-364D3F816C36</gtr:id><gtr:title>Brain monoamine systems in multiple system atrophy: a positron emission tomography study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d066d8e399eeefd6d789616fbf1279"><gtr:id>19d066d8e399eeefd6d789616fbf1279</gtr:id><gtr:otherNames>Lewis SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_15128_28_22266105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C3AB24-E5C0-429E-BE2F-CB5C91374A6F</gtr:id><gtr:title>Reference region automatic extraction in dynamic [(11)C]PIB.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ac1be691b19b518046ec5ac32a7cdd"><gtr:id>77ac1be691b19b518046ec5ac32a7cdd</gtr:id><gtr:otherNames>Ikoma Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_15128_28_23921900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42499521-662E-481E-BD44-A5E66E4038C1</gtr:id><gtr:title>Microglial activation in presymptomatic Huntington's disease gene carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb0a8b16aa776f53413c2aa9f59b14c3"><gtr:id>fb0a8b16aa776f53413c2aa9f59b14c3</gtr:id><gtr:otherNames>Tai YF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>A989A53CEDB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76C58703-888C-4F63-BD40-76B87051EDDF</gtr:id><gtr:title>A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f22d542e94b10777a522a0ea2dd10c81"><gtr:id>f22d542e94b10777a522a0ea2dd10c81</gtr:id><gtr:otherNames>Anderson AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>F996BBFBF25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAF329EC-C838-45DA-A88A-609D7AB498A1</gtr:id><gtr:title>The spectrum of nonmotor symptoms in early Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e3e9549a0b7f3732866d1f551eb3a56"><gtr:id>6e3e9549a0b7f3732866d1f551eb3a56</gtr:id><gtr:otherNames>Khoo TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15128_28_23319473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86D33A4B-E742-49D1-BD9E-1CA32E78FB43</gtr:id><gtr:title>Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa465c7cf5ea8070eb29ebd0e5f4bc03"><gtr:id>aa465c7cf5ea8070eb29ebd0e5f4bc03</gtr:id><gtr:otherNames>Khan NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5CA6E0AFA5F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBCFC2D2-25A3-403B-BBAB-3B5B5F0A3E9A</gtr:id><gtr:title>Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9cca08c6f14fd30dd900e457cc00db2c"><gtr:id>9cca08c6f14fd30dd900e457cc00db2c</gtr:id><gtr:otherNames>Moore RY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>C28CB1E21F5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51EFC8A2-2587-49B9-8AC2-93520A09D1AE</gtr:id><gtr:title>Chronic exposure to dopamine agonists affects the integrity of striatal Dreceptors in Parkinson's patients.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/003ef0c2090080af16a9718d5168846f"><gtr:id>003ef0c2090080af16a9718d5168846f</gtr:id><gtr:otherNames>Politis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>5a8ff524b94675.80389097</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0BA19FB-4BEE-479D-ABEA-E6878CAF5C0A</gtr:id><gtr:title>Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac374eaf02bb39818ac1a7a6da55fb05"><gtr:id>ac374eaf02bb39818ac1a7a6da55fb05</gtr:id><gtr:otherNames>Colasanti A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>56b4a3685e5cf9.05712614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72D360CC-5BFF-4459-AA52-25962A197B32</gtr:id><gtr:title>Using [(11)C]Ro15 4513 PET to characterise GABA-benzodiazepine receptors in opiate addiction: Similarities and differences with alcoholism.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fdb2a9c9fc56464edeebc94d8161093c"><gtr:id>fdb2a9c9fc56464edeebc94d8161093c</gtr:id><gtr:otherNames>Lingford-Hughes A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>5a8ff6f054bad4.24380203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EC91749-1793-4529-845E-D309B680833E</gtr:id><gtr:title>Ventral striatal dopamine synthesis capacity is associated with individual differences in behavioral disinhibition.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45218aeab033c3c90fad61b79a102255"><gtr:id>45218aeab033c3c90fad61b79a102255</gtr:id><gtr:otherNames>Lawrence AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>545793da72d581.17389849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23F44388-6AD8-4A75-A9CD-1007889F773D</gtr:id><gtr:title>Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>56b097179f5203.41261378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9892EEE3-E539-45C8-A021-5080EF264834</gtr:id><gtr:title>Molecular imaging of dopamine transporters.</gtr:title><gtr:parentPublicationTitle>Ageing research reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bc39481bfb591a878dc808e943f2de8"><gtr:id>9bc39481bfb591a878dc808e943f2de8</gtr:id><gtr:otherNames>Brooks DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1568-1637</gtr:issn><gtr:outcomeId>5a8ff7f0e13914.70687361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3247F56-2060-4965-BD06-4401B2A179F0</gtr:id><gtr:title>Factors affecting the clinical outcome after neural transplantation in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d443ffe20ed2f9f0db1d50a4e810ae29"><gtr:id>d443ffe20ed2f9f0db1d50a4e810ae29</gtr:id><gtr:otherNames>Piccini P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>E255F3C9B9D</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U120036861</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>046212FE-8853-46F0-B1E7-3CBA4770A15F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>